Abaloparatide vs Epitalon
Overview
Abaloparatide is primarily a bone & joint peptide, while Epitalon is used for anti-aging & longevity.
This page compares Abaloparatide and Epitalon across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Abaloparatide | Epitalon | |
|---|---|---|
| Category | Bone & Joint | Anti-aging & Longevity |
| Regulatory status (US) | FDA approved | Compounding (Rx) — Apr 2026 |
| Typical dosage | 80 mcg | 5-10 mg |
| Frequency | daily | cycle |
| Reported benefits | Bone building, osteoporosis treatment, reduced fracture risk | Areas studied (research-reported, not established efficacy): telomerase activation and telomere elongation in human cell lines (PMID 12937682; DOI 10.1007/s10522-025-10315-x); increased melatonin synthesis and circadian effects in a small human study; lower overall and cardiovascular mortality in a 12-15 year single-lab trial that used pineal extract (epithalamin), not synthetic AEDG (PMID 17426848, 22451889). No independent multi-center RCTs; not FDA-approved. |
| Reported side effects | Similar to teriparatide but milder | Khavinson-group trials reported no serious adverse events (e.g., n=162 retinitis pigmentosa trial, PMID 12195242), but these are the only controlled safety data and remain unreplicated. Community use reports mild injection-site reactions. Theoretical concern: telomerase activation is a hallmark of most cancers, and a 2025 review (PMC11943447) notes carcinogenic potential is unstudied. No human pharmacokinetic or drug-interaction data. |
Key differences
Primary use. Abaloparatide is categorised under Bone & Joint, while Epitalon falls under Anti-aging & Longevity. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Abaloparatide: FDA-approved. Epitalon: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. Abaloparatide is typically dosed at 80 mcg (daily). Epitalon is typically dosed at 5-10 mg (cycle).
Can you stack them?
Some protocols combine peptides, but stacking Abaloparatide and Epitalon has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Abaloparatide and Epitalon?
- Abaloparatide is primarily a bone & joint peptide, while Epitalon is used for anti-aging & longevity. Abaloparatide is FDA-approved for one or more indications, whereas Epitalon is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is Abaloparatide used for?
- Advanced bone anabolic.
- What is Epitalon used for?
- Longevity, telomere support.
- Can you take Abaloparatide and Epitalon together?
- Some users combine peptides within a single protocol, but stacking Abaloparatide and Epitalon has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Abaloparatide or Epitalon FDA-approved?
- Abaloparatide is FDA-approved for one or more indications. Epitalon is not FDA-approved; compounding permitted with a prescription (as of April 2026).
Read the full articles
- Abaloparatide — full monograph: mechanism, research, dosing & references
- Epitalon — full monograph: mechanism, research, dosing & references